[Time of maintenance therapy in acute lymphatic leukemias of childhood].
D002471:Cell Transformation, Neoplastic; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D012075:Remission, Spontaneous; D013997:Time Factors
D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
Die Dauer der Erhaltungstherapie akuter lymphatischer Leukämien im Kindesalter